Larger Posterior Revascularization Associated with Reduction of Choroidal Anastomosis in Moyamoya Disease: A Quantitative Angiographic Analysis

References

1. 1.↵
   1. Funaki T,
   2. Takahashi JC,
   3. Houkin K, et al

   . Angiographic features of hemorrhagic Moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 2018;128:777–84 doi:10.3171/2016.11.JNS161650 pmid:28409736

   CrossRefPubMed
2. 2.↵
   1. Funaki T,
   2. Takahashi JC,
   3. Yoshida K, et al

   . Periventricular anastomosis in Moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg 2016;124:1766–72 doi:10.3171/2015.6.JNS15845 pmid:26613176

   CrossRefPubMed
3. 3.↵
   1. Funaki T,
   2. Fushimi Y,
   3. Takahashi JC, et al

   . Visualization of periventricular collaterals in Moyamoya disease with flow-sensitive black-blood magnetic resonance angiography: preliminary experience. Neurol Med Chir (Tokyo) 2015;55:204–09 doi:10.2176/nmc.oa.2014-0360 pmid:25739429

   CrossRefPubMed
4. 4.↵
   1. Funaki T,
   2. Takahashi JC,
   3. Houkin K, et al

   . Effect of choroidal collateral vessels on de novo hemorrhage in Moyamoya disease: analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial. J Neurosurg 2019;132:408–14 doi:10.3171/2018.10.JNS181139 pmid:30738387

   CrossRefPubMed
5. 5.↵
   1. Funaki T,
   2. Takahashi JC,
   3. Houkin K, et al

   . High rebleeding risk associated with choroidal collateral vessels in hemorrhagic Moyamoya disease: analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg 2019;130:525–30 doi:10.3171/2017.9.JNS17576 pmid:29498573

   CrossRefPubMed
6. 6.↵
   1. Miyakoshi A,
   2. Funaki T,
   3. Takahashi JC, et al

   . Restoration of periventricular vasculature after direct bypass for Moyamoya disease: intra-individual comparison. Acta Neurochir (Wien) 2019;161:947–54 doi:10.1007/s00701-019-03866-9 pmid:30880348

   CrossRefPubMed
7. 7.↵
   1. Irikura K,
   2. Miyasaka Y,
   3. Kurata A, et al

   . A source of haemorrhage in adult patients with Moyamoya disease: the significance of tributaries from the choroidal artery. Acta Neurochir (Wien) 1996;138:1282–86 doi:10.1007/BF01411056 pmid:8980730

   CrossRefPubMed
8. 8.
   1. Morioka M,
   2. Hamada J,
   3. Kawano T, et al

   . Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult Moyamoya patients. Stroke 2003;34:90–95 doi:10.1161/01.STR.0000047120.67507.0D pmid:12511756

   Abstract/FREE Full Text
9. 9.↵
   1. Fujimura M,
   2. Funaki T,
   3. Houkin K, et al

   . Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset Moyamoya disease: case-control study of the Japan Adult Moyamoya Trial. J Neurosurg 2019;130:1453–59 doi:10.3171/2017.11.JNS171990 pmid:29726780

   CrossRefPubMed
10. 10.↵
    1. Wang J,
    2. Yang Y,
    3. Li X, et al

    . Lateral posterior choroidal collateral anastomosis predicts recurrent ipsilateral hemorrhage in adult patients with Moyamoya disease. AJNR Am J Neuroradiol 2019;40:1665–71 doi:10.3174/ajnr.A6208 pmid:31537520

    Abstract/FREE Full Text
11. 11.↵
    1. Jang DK,
    2. Lee KS,
    3. Rha HK, et al

    . Bypass surgery versus medical treatment for symptomatic Moyamoya disease in adults. J Neurosurg 2017;127:492–502 doi:10.3171/2016.8.JNS152875 pmid:27834597

    CrossRefPubMed
12. 12.↵
    1. Miyamoto S,
    2. Yoshimoto T,
    3. Hashimoto N, et al

    ; JAM Trial Investigators. Effects of extracranial-intracranial bypass for patients with hemorrhagic Moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 2014;45:1415–21 doi:10.1161/STROKEAHA.113.004386 pmid:24668203

    Abstract/FREE Full Text
13. 13.
    1. Jeon JP,
    2. Kim JE,
    3. Cho WS, et al

    . Meta-analysis of the surgical outcomes of symptomatic Moyamoya disease in adults. J Neurosurg 2018;128:793–99 doi:10.3171/2016.11.JNS161688 pmid:28474994

    CrossRefPubMed
14. 14.↵
    1. Ding J,
    2. Zhou D,
    3. Paul Cosky EE, et al

    . Hemorrhagic Moyamoya disease treatment: a network meta-analysis. World Neurosurg 2018;117:e557–62 doi:10.1016/j.wneu.2018.06.076 pmid:29933090

    CrossRefPubMed
15. 15.↵
    1. Yamamoto S,
    2. Kashiwazaki D,
    3. Uchino H, et al

    . Ameliorative effects of combined revascularization surgery on abnormal collateral channels in Moyamoya disease. J Stroke Cerebrovasc Dis 2021;30:105624 doi:10.1016/j.jstrokecerebrovasdis.2021.105624 pmid:33516067

    CrossRefPubMed
16. 16.↵
    1. Miyakoshi A,
    2. Funaki T,
    3. Fushimi Y, et al

    . Cortical distribution of fragile periventricular anastomotic collateral vessels in Moyamoya disease: an exploratory cross-sectional study of Japanese patients with Moyamoya disease. AJNR Am J Neuroradiol 2020;41:2243–49 doi:10.3174/ajnr.A6861 pmid:33154076

    Abstract/FREE Full Text
17. 17.↵
    Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases. Guidelines for diagnosis and treatment of Moyamoya disease (spontaneous occlusion of the Circle of Willis). Neurol Med Chir (Tokyo) 2012;52:245–66 doi:10.2176/nmc.52.245 pmid:22870528

    CrossRefPubMed
18. 18.↵
    1. Karasawa J,
    2. Touho H,
    3. Ohnishi H, et al

    . Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood Moyamoya disease. J Neurosurg 1992;77:84–89 doi:10.3171/jns.1992.77.1.0084 pmid:1607976

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Bang JS,
    2. Kwon OK,
    3. Kim JE, et al

    . Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult Moyamoya disease. Neurosurgery 2012;70:625–32 doi:10.1227/NEU.0b013e3182333c47 pmid:21866061

    CrossRefPubMed
20. 20.↵
    1. Rhoton AL Jr..

    The cerebrum. Neurosurgery 2002;51:S1–51 doi:10.1097/00006123-200210001-00002 pmid:12234446

    CrossRefPubMed
21. 21.↵
    1. Sun A,
    2. Hou L,
    3. Cheshier S, et al

    . The accuracy of topographical methods in determining central sulcus: a statistical correlation between modern imaging data and these historical predications. Cureus 2014;6:e186 doi:10.7759/cureus.186

    CrossRef
22. 22.↵
    1. Reis CV,
    2. Sankar T,
    3. Crusius M, et al

    . Comparative study of cranial topographic procedures: Broca’s legacy toward practical brain surgery. Neurosurgery 2008;62:294–310 doi:10.1227/01.neu.0000315997.50399.91 pmid:18382308

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Suzuki J,
    2. Kodama N

    . Moyamoya disease: a review. Stroke 1983;14:104–09 doi:10.1161/01.str.14.1.104 pmid:6823678

    Abstract/FREE Full Text
24. 24.↵
    1. Funaki T,
    2. Takahashi JC,
    3. Takagi Y, et al

    . Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric Moyamoya disease. J Neurosurg Pediatr 2013;12:626–32 doi:10.3171/2013.9.PEDS13111 pmid:24138143

    CrossRefPubMed
25. 25.↵
    1. Karasawa J,
    2. Kikuchi H,
    3. Furuse S, et al

    . A surgical treatment of “Moyamoya” disease “encephalo-myo synangiosis.” Neurol Med Chir (Tokyo) 1977;17(1 Pt 1):29–37 doi:10.2176/nmc.17pt1.29 pmid:74029

    CrossRefPubMed
26. 26.↵
    1. Takahashi JC,
    2. Funaki T,
    3. Houkin K, et al

    . Impact of cortical hemodynamic failure on both subsequent hemorrhagic stroke and effect of bypass surgery in hemorrhagic Moyamoya disease: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 2021;134:940–45 doi:10.3171/2020.1.JNS192392 pmid:32168484

    CrossRefPubMed
27. 27.↵
    1. Ogura T,
    2. Hida K,
    3. Masuzuka T, et al

    . An automated ROI setting method using NEUROSTAT on cerebral blood flow SPECT images. Ann Nucl Med 2009;23:33–41 doi:10.1007/s12149-008-0203-7 pmid:19205836

    CrossRefPubMed
28. 28.↵
    1. Jiang H,
    2. Ni W,
    3. Xu B, et al

    . Outcome in adult patients with hemorrhagic Moyamoya disease after combined extracranial-intracranial bypass. J Neurosurg 2014;121:1048–55 doi:10.3171/2014.7.JNS132434 pmid:25127415

    CrossRefPubMed
29. 29.↵
    1. Irikura K,
    2. Miyasaka Y,
    3. Kurata A, et al

    . The effect of encephalo-myo-synangiosis on abnormal collateral vessels in childhood Moyamoya disease. Neurol Res 2000;22:341–46 doi:10.1080/01616412.2000.11740680 pmid:10874680

    CrossRefPubMed
30. 30.↵
    1. Takahashi JC,
    2. Funaki T,
    3. Houkin K

    , et al; JAM Trial Investigators. Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial. Stroke 2016;47:37–43 doi:10.1161/STROKEAHA.115.010819 pmid:26645256

    Abstract/FREE Full Text
31. 31.↵
    1. Funaki T,
    2. Kataoka H,
    3. Yoshida K, et al

    . The targeted bypass strategy for preventing hemorrhage in Moyamoya disease: technical note. Neurol Med Chir (Tokyo) 2019;59:517–22 doi:10.2176/nmc.tn.2019-0162 pmid:31656238

    CrossRefPubMed
32. 32.↵
    1. Kuroda S,
    2. Houkin K,
    3. Ishikawa T, et al

    . Novel bypass surgery for Moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery 2010;66:1093–101 doi:10.1227/01.NEU.0000369606.00861.91 pmid:20495424

    CrossRefPubMedWeb of Science
33. 33.
    1. Houkin K,
    2. Kamiyama H,
    3. Takahashi A, et al

    . Combined revascularization surgery for childhood Moyamoya disease: STA-MCA and encephalo-duro-arterio-myo-synangiosis. Childs Nerv Syst 1997;13:24–29 doi:10.1007/s003810050034 pmid:9083698

    CrossRefPubMedWeb of Science
34. 34.
    1. Matsushima T,
    2. Inoue T,
    3. Suzuki SO, et al

    . Surgical treatment of Moyamoya disease in pediatric patients: comparison between the results of indirect and direct revascularization procedures. Neurosurgery 1992;31:401–05 doi:10.1227/00006123-199209000-00003 pmid:1407421

    CrossRefPubMedWeb of Science
35. 35.
    1. Kim DS,
    2. Yoo DS,
    3. Huh PW, et al

    . Combined direct anastomosis and encephaloduroarteriogaleosynangiosis using inverted superficial temporal artery-galeal flap and superficial temporal artery-galeal pedicle in adult Moyamoya disease. Surg Neurol 2006;66:389–94 doi:10.1016/j.surneu.2006.02.047 pmid:17015118

    CrossRefPubMed
36. 36.
    1. Acker G,
    2. Fekonja L,
    3. Vajkoczy P

    . Surgical management of Moyamoya disease. Stroke 2018;49:476–82 doi:10.1161/STROKEAHA.117.018563 pmid:29343587

    FREE Full Text
37. 37.
    1. Guzman R,
    2. Steinberg GK

    . Direct bypass techniques for the treatment of pediatric Moyamoya disease. Neurosurg Clin N Am.2010;21:565–73 doi:10.1016/j.nec.2010.03.013 pmid:20561504

    CrossRefPubMed
38. 38.
    1. Fujimura M,
    2. Tominaga T

    . Lessons learned from Moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo) 2012;52:327–32 doi:10.2176/nmc.52.327 pmid:22688070

    CrossRefPubMed
39. 39.↵
    1. Wanebo JE,
    2. Zabramski JM,
    3. Spetzler RF

    . Superficial temporal artery-to-middle cerebral artery bypass grafting for cerebral revascularization. Neurosurgery 2004;55:395–98 doi:10.1227/01.neu.0000129549.99061.94 pmid:15271247

    CrossRefPubMed